XML 15 R2.htm IDEA: XBRL DOCUMENT v3.25.2
CONSOLIDATED BALANCE SHEET - USD ($)
$ in Millions
Jun. 30, 2025
Dec. 31, 2024
Investments:    
Fixed maturities, available for sale, at fair value (net of allowance for credit losses: June 30, 2025 - $39.1 and December 31, 2024 - $37.1; amortized cost: June 30, 2025 - $25,228.8 and December 31, 2024 - $25,151.0) $ 23,047.0 $ 22,730.1
Equity securities at fair value 387.4 272.4
Mortgage loans (net of allowance for credit losses: June 30, 2025 - $21.1 and December 31, 2024 - $13.6) 2,834.3 2,506.3
Policy loans 137.6 135.3
Trading securities 308.3 304.2
Investments held by variable interest entities (net of allowance for credit losses: June 30, 2025 - $2.3 and December 31, 2024 - $1.3; amortized cost: June 30, 2025 - $380.9 and December 31, 2024 - $437.0 376.9 433.8
Other invested assets 1,500.5 1,491.5
Total investments 28,592.0 27,873.6
Cash and cash equivalents - unrestricted 766.0 1,656.7
Cash and cash equivalents held by variable interest entities 50.0 341.0
Accrued investment income 279.4 286.4
Present value of future profits 152.1 161.0
Deferred acquisition costs 2,276.3 2,158.6
Reinsurance receivables (net of allowance for credit losses: June 30, 2025 - $1.0 and December 31, 2024 - $3.0) 3,753.9 3,854.7
Income tax assets, net 749.3 814.1
Assets held in separate accounts 2.9 3.3
Other assets 707.2 699.9
Total assets 37,329.1 37,849.3
Liabilities for insurance products:    
Policyholder account balances 17,609.0 17,594.2
Future policy benefits 11,787.7 11,705.5
Market risk benefit liability 63.8 60.0
Liability for life insurance policy claims 60.7 61.1
Unearned and advanced premiums 217.3 226.8
Liabilities related to separate accounts 2.9 3.3
Other liabilities 935.8 1,163.3
Investment borrowings 2,441.7 2,188.8
Borrowings related to variable interest entities 352.8 497.6
Notes payable – direct corporate obligations 1,334.7 1,833.5
Total liabilities 34,806.4 35,334.1
Commitments and Contingencies (Note 14)
Shareholders' equity:    
Common stock ($0.01 par value, 8,000,000,000 shares authorized, shares issued and outstanding: June 30, 2025 – 97,319,000; December 31, 2024 – 101,618,957) 1.0 1.0
Additional paid-in capital 1,441.4 1,632.5
Accumulated other comprehensive loss (1,252.7) (1,371.4)
Retained earnings 2,333.0 2,253.1
Total shareholders' equity 2,522.7 2,515.2
Total liabilities and shareholders' equity $ 37,329.1 $ 37,849.3